DNA therapy effective against chemo-resistant ovarian cancer
Drug Discovery World
DECEMBER 4, 2023
A novel DNA vaccine in combination with chemotherapy has demonstrated promising clinical results against a deadly form of ovarian cancer. The investigational compound Elenagen is an experimental DNA therapy that consists of a circular piece of DNA called a plasmid that includes a gene for a human protein called p62/SQSTM1. In a new paper, a team of scientists from CureLab Oncology, the NN Alexandrov National Cancer Center and Minsk City Oncology Center have demonstrated a clear clinical benefit
Let's personalize your content